An unexpected finding was that administration of OVA resulted in decreased ENO in NOS-2-/- mice, previously measured to be high when naive (Figures 2 and 6), coupled with the lack of cell recruitment and eosinophilia (Table 1). The gene discussed is NOS2; the disease is Increased total eosinophil count.